Clinical Trials Logo

Partial Onset Seizures clinical trials

View clinical trials related to Partial Onset Seizures.

Filter by:

NCT ID: NCT01147003 Completed - Clinical trials for Partial Onset Seizures

Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures

Start date: June 2010
Phase: Phase 2
Study type: Interventional

This study will assess the efficacy and safety of BGG492 as adjunctive treatment in patients with partial onset seizures.

NCT ID: NCT01051193 Completed - Clinical trials for Partial Onset Seizures

Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures

Start date: January 5, 2010
Phase: Phase 2/Phase 3
Study type: Interventional

This study is designed to provide long term safety data of TRI476 in children with inadequately-controlled partial seizures. This study is conducted in patients who complete the core study CTRI476B1301. Blinding is maintained during the transition and dose adjustment phase of the extension study. All patients are treated with TRI476 from the dose adjustment phase onwards. The purpose of study is to confirm that TRI476 as adjunctive therapy is safe.

NCT ID: NCT00975715 Completed - Clinical trials for Partial Onset Seizures

Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures

Start date: September 2009
Phase: Phase 2/Phase 3
Study type: Interventional

This study is designed to provide short term efficacy and safety data of TRI476 in children with inadequately-controlled partial seizures. Patients will be randomized into either drug treatment or placebo group at 1:1 ratio, and receive their respective treatment for 8 weeks. The purpose of study is to confirm that TRI476 as adjunctive therapy is effective and safe.

NCT ID: NCT00655551 Completed - Clinical trials for Partial Onset Seizures

Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures

Start date: April 2008
Phase: Phase 3
Study type: Interventional

The purpose of the trial is to evaluate the safety of intravenous (iv) lacosamide delivered in a single dose followed by 6.5 days of oral lacosamide treatment in subjects with partial-onset seizures.

NCT ID: NCT00655486 Completed - Clinical trials for Partial Onset Seizures

Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures

Start date: April 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to allow eligible subjects from the parent study, SP925 [NCT00655551] to continue lacosamide and to obtain additional long-term safety data

NCT ID: NCT00235755 Completed - Clinical trials for Partial-Onset Seizures

Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy

RESTORE2
Start date: December 2005
Phase: Phase 3
Study type: Interventional

This Phase 3 study is being conducted to evaluate the efficacy and safety of retigabine dosed at 900 mg/day and 600 mg/day, in three equally divided doses, compared with placebo in patients with epilepsy who are receiving up to three established antiepileptic drugs (AEDs).

NCT ID: NCT00232596 Completed - Clinical trials for Partial-Onset Seizures

Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy

RESTORE1
Start date: September 2005
Phase: Phase 3
Study type: Interventional

This Phase 3 study is being conducted to evaluate the efficacy and safety of retigabine dosed at 1200 mg/day, in three equally divided doses, compared with placebo in patients with epilepsy who are receiving up to three established antiepileptic drugs (AEDs).